Instem Past Earnings Performance

Past criteria checks 4/6

Instem has been growing earnings at an average annual rate of 30.1%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 24.2% per year. Instem's return on equity is 6.1%, and it has net margins of 5.4%.

Key information

30.1%

Earnings growth rate

20.8%

EPS growth rate

Healthcare Services Industry Growth12.5%
Revenue growth rate24.2%
Return on equity6.1%
Net Margin5.4%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Here's Why We Think Instem (LON:INS) Might Deserve Your Attention Today

Oct 14
Here's Why We Think Instem (LON:INS) Might Deserve Your Attention Today

An Intrinsic Calculation For Instem plc (LON:INS) Suggests It's 29% Undervalued

Aug 31
An Intrinsic Calculation For Instem plc (LON:INS) Suggests It's 29% Undervalued

Instem plc (LON:INS) Shares Could Be 45% Below Their Intrinsic Value Estimate

Jan 25
Instem plc (LON:INS) Shares Could Be 45% Below Their Intrinsic Value Estimate

Instem plc's (LON:INS) Intrinsic Value Is Potentially 44% Above Its Share Price

Sep 04
Instem plc's (LON:INS) Intrinsic Value Is Potentially 44% Above Its Share Price

Is Instem plc's (LON:INS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Mar 03
Is Instem plc's (LON:INS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Shareholders Are Thrilled That The Instem (LON:INS) Share Price Increased 190%

Jan 29
Shareholders Are Thrilled That The Instem (LON:INS) Share Price Increased 190%

Calculating The Intrinsic Value Of Instem plc (LON:INS)

Dec 25
Calculating The Intrinsic Value Of Instem plc (LON:INS)

Revenue & Expenses Breakdown

How Instem makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:INS Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2362300
31 Mar 2360400
31 Dec 2259500
30 Sep 2256300
30 Jun 2253200
31 Mar 2250200
31 Dec 2146200
30 Sep 2140200
30 Jun 2134200
31 Mar 2131200
31 Dec 2028200
30 Sep 2028100
30 Jun 2028000
31 Mar 2027000
31 Dec 1926-100
30 Sep 1925000
30 Jun 1924210
31 Mar 1923210
31 Dec 1823110
30 Sep 1822110
30 Jun 1821110
31 Mar 1821110
31 Dec 1721110
30 Sep 1720010
30 Jun 1720010
31 Mar 1719110
31 Dec 1618110
30 Sep 1618010
30 Jun 1618-110
31 Mar 1617010
31 Dec 1516010
30 Sep 1516010
30 Jun 1515110
31 Mar 1514110
31 Dec 1413010
30 Sep 1413010
30 Jun 1412010
31 Mar 1411010
31 Dec 1311110
30 Sep 1311110
30 Jun 1311110
31 Mar 1311110
31 Dec 1211110

Quality Earnings: INS has a large one-off loss of £1.1M impacting its last 12 months of financial results to 30th June, 2023.

Growing Profit Margin: INS's current net profit margins (5.4%) are higher than last year (3.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: INS's earnings have grown significantly by 30.1% per year over the past 5 years.

Accelerating Growth: INS's earnings growth over the past year (68.1%) exceeds its 5-year average (30.1% per year).

Earnings vs Industry: INS earnings growth over the past year (68.1%) exceeded the Healthcare Services industry 6.5%.


Return on Equity

High ROE: INS's Return on Equity (6.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/21 12:12
End of Day Share Price 2023/11/20 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Instem plc is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Greig AitkenNplus1 Brewin
Christopher GlasperNplus1 Brewin
Gareth EvansProgressive Equity Research